A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy (PRONTO-Pump-2)

The reason for this study is to compare the study drug LY900014 to insulin lispro when both are used in insulin pump therapy in adults with type 1 diabetes (T1D).

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
Insulin Lispro, Ultra-Rapid Lispro
Could I receive a Placebo?
No
Enrollment Goal
471
Trial Dates
Feb 14, 2019 - Jan 6, 2020
How long will I be in the trial?
The study will last about 23 weeks and may include up to 12 clinic visits and 2 telephone appointments.
Trial Phase
III

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.